US FDA adds rare vision-loss warning to popular GLP-1 drugs

Economic Times - Nov 10, 2026

The US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound. The condition was found in around 6 per 100,000 patients taking the drugs for at least a year.

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.